U.S. REITS Stock News

Repligen (RGEN) is back in focus after its first quarter 2026 earnings, where profit topped market expectations, full year adjusted earnings guidance moved higher, and the stock gained 7.3% on the news. See our latest analysis for Repligen. Beyond the post earnings jump, Repligen’s 7 day share price return of 6.86% and 30 day share price return of 9.66% sit against a year to date share price decline of 23.07%. The 1 year total shareholder return of a 1.11% decline and 3 year total shareholder...

What Crane’s latest earnings and M&A comments mean for investors Crane (CR) just paired a Q1 earnings beat with a slight uptick in full year adjusted EPS guidance, yet a softer operating margin and active acquisition agenda are shaping how investors reassess the stock. See our latest analysis for Crane. Crane’s recent Q1 earnings beat, slight full year EPS guidance increase, dividend affirmation, and active M&A commentary come after a 1 year total shareholder return of 7.6%. The 3 year total...

In early May 2026, Clean Harbors, Inc. reported first-quarter 2026 results showing revenue of US$1,459.54 million and net income of US$63.2 million, and issued full-year 2026 GAAP net income guidance of US$421 million to US$472 million. The quarter also featured record safety performance, strong landfill volume growth tied to PFAS and project work, and higher full-year adjusted EBITDA guidance supported by operational efficiency initiatives, including AI deployment and new field service...

Recently, Legend Biotech expanded its scientific advisory board with six leading experts in oncology and cell therapy and, together with Janssen, agreed to increase CARVYKTI manufacturing capacity at Janssen’s Raritan, New Jersey facility to support its cell therapy ambitions. This combination of deeper scientific guidance and scaled manufacturing marks a meaningful step in Legend’s efforts to build an end-to-end cell therapy platform targeting high unmet medical needs. We’ll now examine how...

In the first quarter of 2026, First Solar reported sales of US$1,044.24 million and net income of US$346.62 million, with basic earnings per share from continuing operations of US$3.23, all higher than a year earlier. Alongside these results, the company reaffirmed its 2026 outlook, including expected module volumes of 17.0–18.2 GW and net sales of US$4.90–US$5.20 billion, reinforcing visibility into its order book and manufacturing plans. Building on this earnings strength and reaffirmed...

Estée Lauder Companies (NYSE:EL) agreed to a US$210 million settlement of a shareholder lawsuit over disclosure of grey-market sales in China. The company also announced a global workforce reduction targeting up to 10,000 jobs, nearly 20% of staff, under its expanded Profit Recovery and Growth Plan. Job cuts are expected to focus on department store beauty advisors, with a pivot toward digital channels and different selling models. For investors following NYSE:EL, these moves come at a time...

DigitalOcean Holdings (NYSE:DOCN) has rolled out an AI-Native Cloud platform with a new Inference Engine, presented at its Deploy 2026 event. The company completed an $888 million equity raise aimed at funding AI infrastructure and strengthening its balance sheet. Market attention has increased alongside analyst upgrades and DigitalOcean’s move from the S&P SmallCap 600 to the S&P MidCap 400. DigitalOcean’s repositioning around AI-focused cloud services is coming at a time when the stock...

Why Saia (SAIA) is on investors’ radar right now Saia (SAIA) has drawn fresh attention after a recent share price move, with the stock showing strong trailing returns over the past year and past 3 months. This performance has prompted closer scrutiny of its fundamentals. See our latest analysis for Saia. Despite a small 1-day share price decline, Saia’s 30-day share price return of 19.52% and 1-year total shareholder return of 68.91% point to momentum building on top of its longer term...

In recent weeks, Encompass Health Corporation reported higher first‑quarter 2026 sales of US$1,586.6 million and net income of US$194.5 million, raised its full‑year net operating revenue guidance, continued share repurchases under its long‑running buyback, opened a new 50‑bed rehabilitation hospital in Concordville, Pennsylvania, and declared a quarterly dividend of US$0.19 per share payable on July 15, 2026. Together, the earnings beat, guidance increase, capacity expansion and ongoing...

In the first quarter of 2026, AGCO Corporation reported higher sales of US$2,342.9 million and net income of US$55.0 million, while also completing a US$250.0 million share repurchase program under its existing authorization. The company reinforced its disciplined capital allocation approach by accelerating technology-focused acquisitions, boosting shareholder returns through higher dividends and additional buybacks, and reshaping its financing joint ventures in North America. With AGCO now...

Gap Inc. co founder Doris Fisher has died at age 94. Her passing marks an important moment for NYSE:GAP, given her role in shaping the company’s identity, culture, and creative direction. The news comes as Gap continues its focus on brand reinvigoration and broader business transformation. For investors watching NYSE:GAP, this moment comes with the stock trading around $23.9, after a 6.8% gain over the past year and a very large return over three years. Over five years the stock shows a...

Merck (NYSE:MRK) faces an upcoming Gardasil vaccine safety trial scheduled for late July, focusing on product safety and potential liability claims. The company has also published new research on a large scale, enzyme enabled synthesis route for its oral PCSK9 inhibitor candidate. This synthesis work could help support development of what may become one of the first oral PCSK9 treatments for cholesterol management. Merck enters these developments with its stock at $112.3 and a return of...

There's been a notable change in appetite for SmartRent, Inc. ( NYSE:SMRT ) shares in the week since its quarterly...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

The latest earnings release from NCS Multistage Holdings, Inc. ( NASDAQ:NCSM ) disappointed investors. We did some...

Mettler-Toledo International (MTD) closed out FY 2025 with fourth quarter revenue of US$1,129.7 million and basic EPS of US$14.02, setting the tone for a year where trailing twelve month revenue reached US$4.0 billion and EPS came in at US$42.17. Over recent quarters the company has seen revenue move from US$954.5 million in Q3 2024 to US$1,129.7 million in Q4 2025, while quarterly EPS stepped from US$10.01 to US$14.02. This has left investors focused on how these trends flow through to...

Tradeweb Markets Inc. reported that in April 2026 it handled total trading volume of US$62.20 trillion, with average daily volume rising 7.7% year over year, and recently posted first-quarter 2026 revenue of US$617.76 million and net income of US$205.28 million, both higher than a year earlier. Alongside these results, Tradeweb affirmed a quarterly dividend of US$0.14 per share, highlighting ongoing cash returns to shareholders as electronic trading activity across multiple asset classes...

SPS Commerce, Inc. reported past first-quarter 2026 results with revenue of US$192.12 million, up from US$181.55 million a year earlier, while net income eased to US$19.73 million and diluted EPS to US$0.53. Alongside completing a US$63.64 million share repurchase program, the company issued 2026 guidance pointing to further revenue growth and steady profitability, highlighting management’s confidence in its business model. Next, we’ll examine how SPS Commerce’s revenue growth outlook and...

If you are wondering whether Miami International Holdings at around US$49.77 is priced attractively or not, the key question is how that tag compares with what the business could reasonably be worth. Over shorter periods, the stock has been active, with returns of 7.1% over the last 7 days, 20.5% over the last 30 days and 14.0% year to date, which hints that expectations and perceived risk are shifting. Recent coverage has focused on Miami International Holdings as part of broader...

Essent Group (ESNT) closed out FY 2025 with fourth quarter revenue of US$312.4 million and basic EPS of US$1.62, while trailing twelve month revenue stood at US$1.3 billion with EPS of US$6.97. Over recent quarters, revenue has ranged from US$311.8 million to US$319.1 million, with quarterly EPS between US$1.60 and US$1.95. Trailing net income over the past year moved between US$690.0 million and US$736.9 million as margins eased from 58.7% to 54.7%, setting up a results snapshot where...

Investors may be wondering if Qorvo at around US$88.97 is still offering value, or if most of the upside has already been priced in. The stock has had a mixed run, with a 22.9% return over the last year, a 14.4% gain over the past month and a 5.6% decline over the last week. Over five years, the return sits at a 46.7% loss. Recent price moves sit against a backdrop of ongoing interest in semiconductor stocks generally, as investors reassess which companies could benefit most from demand for...

SES AI (NYSE:SES) has converted its South Korea facility to produce NDAA-compliant drone battery cells for defense customers. The company signed a multi-year, $20 million distribution agreement with ATG EPower for North American energy storage systems. SES AI is applying AI tools to optimize defense-focused battery products, expanding its use of the technology beyond R&D. SES AI, trading at about $0.921 per share, is shifting focus beyond long-cycle EV battery development toward products...

Dell Technologies (NYSE:DELL) has agreed to work with TotalEnergies and NVIDIA on Pangea 5, a next generation high performance supercomputer. The project focuses on large scale, AI driven computing infrastructure for energy, research, and advanced analytics use cases. Pangea 5 is designed with energy efficient architecture aimed at supporting complex industrial and scientific workloads. For readers tracking NYSE:DELL, this contract highlights the company’s role in supplying core...

Catalyst Pharmaceuticals (NasdaqCM:CPRX) has settled all pending FIRDAPSE patent litigation with Hetero Labs. The agreement prevents Hetero from launching a generic FIRDAPSE product in the U.S. before January 2035. The settlement secures extended U.S. market exclusivity for FIRDAPSE and removes a key legal overhang for Catalyst. Catalyst Pharmaceuticals focuses on treatments for rare neurological diseases, with FIRDAPSE as its lead commercial product. In that context, the settlement with...